{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T20:34:32Z","timestamp":1785443672512,"version":"3.56.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"13","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.vaccine.2016.02.025","type":"journal-article","created":{"date-parts":[[2016,2,17]],"date-time":"2016-02-17T15:16:24Z","timestamp":1455722184000},"page":"1524-1530","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Delta- pgm , a new live-attenuated vaccine against Brucella suis"],"prefix":"10.1016","volume":"34","author":[{"given":"Cecilia","family":"Czibener","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariela Giselda","family":"Del Giudice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Manuel","family":"Spera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiana Rosa","family":"Fulgenzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8301-8091","authenticated-orcid":false,"given":"Juan Esteban","family":"Ugalde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2016.02.025_bib0120","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.cmi.2015.04.011","article-title":"The neglected zoonoses \u2013 the case for integrated control and advocacy","volume":"21","author":"Welburn","year":"2015","journal-title":"Clin Microbiol Infect: Off Publ Eur Soc Clin Microbiol Infect Dis"},{"key":"10.1016\/j.vaccine.2016.02.025_bib0125","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3201\/eid0302.970219","article-title":"Brucellosis: an overview","volume":"3","author":"Corbel","year":"1997","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2016.02.025_bib0130","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1056\/NEJMra050570","article-title":"Brucellosis","volume":"352","author":"Pappas","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2016.02.025_bib0135","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0378-1135(02)00255-9","article-title":"Brucellosis vaccines: past, present and future","volume":"90","author":"Schurig","year":"2002","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2016.02.025_bib0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1051\/vetres:2003037","article-title":"Rough vaccines in animal brucellosis: structural and genetic basis and present status","volume":"35","author":"Moriyon","year":"2004","journal-title":"Vet Res"},{"key":"10.1016\/j.vaccine.2016.02.025_bib0145","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0378-1135(02)00247-X","article-title":"Brucellosis in Argentina","volume":"90","author":"Samartino","year":"2002","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2016.02.025_bib0150","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1177\/0300985814540545","article-title":"Advancement of knowledge of Brucella over the past 50 years","volume":"51","author":"Olsen","year":"2014","journal-title":"Vet Pathol"},{"key":"10.1016\/j.vaccine.2016.02.025_bib0155","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0378-1135(02)00252-3","article-title":"Epidemiology and control of brucellosis in China","volume":"90","author":"Deqiu","year":"2002","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2016.02.025_bib0160","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/0264-410X(90)90247-J","article-title":"Brucella suis S2, Brucella melitensis Rev. 1 and Brucella abortus S19 living vaccines: residual virulence and immunity induced against three Brucella species challenge strains in mice","volume":"8","author":"Bosseray","year":"1990","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.02.025_bib0165","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/0264-410X(93)90097-H","article-title":"Efficacy of Brucella suis strain 2 vaccine against Brucella ovis in rams","volume":"11","author":"Blasco","year":"1993","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.02.025_bib0170","doi-asserted-by":"crossref","first-page":"6264","DOI":"10.1128\/IAI.71.11.6264-6269.2003","article-title":"Evaluation of Brucella abortus phosphoglucomutase (pgm) mutant as a new live rough-phenotype vaccine","volume":"71","author":"Ugalde","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2016.02.025_bib0175","doi-asserted-by":"crossref","first-page":"5716","DOI":"10.1128\/IAI.68.10.5716-5723.2000","article-title":"Identification and characterization of the Brucella abortus phosphoglucomutase gene: role of lipopolysaccharide in virulence and intracellular multiplication","volume":"68","author":"Ugalde","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2016.02.025_bib0180","doi-asserted-by":"crossref","first-page":"4528","DOI":"10.1128\/IAI.69.7.4528-4535.2001","article-title":"Brucella abortus cyclic beta-1,2-glucan mutants have reduced virulence in mice and are defective in intracellular replication in HeLa cells","volume":"69","author":"Briones","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2016.02.025_bib0185","doi-asserted-by":"crossref","first-page":"4392","DOI":"10.1128\/JB.180.17.4392-4400.1998","article-title":"Molecular cloning and characterization of cgs, the Brucella abortus cyclic beta(1-2) glucan synthetase gene: genetic complementation of Rhizobium meliloti ndvB and Agrobacterium tumefaciens chvB mutants","volume":"180","author":"Inon de Iannino","year":"1998","journal-title":"J Bacteriol"},{"key":"10.1016\/j.vaccine.2016.02.025_bib0190","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.micinf.2011.08.012","article-title":"Identification of a unique gene cluster of Brucella spp. that mediates adhesion to host cells","volume":"14","author":"Czibener","year":"2012","journal-title":"Microbes Infect"},{"key":"10.1016\/j.vaccine.2016.02.025_bib0195","doi-asserted-by":"crossref","first-page":"4849","DOI":"10.1128\/JB.182.17.4849-4855.2000","article-title":"A homologue of an operon required for DNA transfer in Agrobacterium is required in Brucella abortus for virulence and intracellular multiplication","volume":"182","author":"Sieira","year":"2000","journal-title":"J Bacteriol"},{"key":"10.1016\/j.vaccine.2016.02.025_bib0200","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0165-2427(94)05361-U","article-title":"Improved competitive enzyme immunoassay for the diagnosis of bovine brucellosis","volume":"46","author":"Nielsen","year":"1995","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.vaccine.2016.02.025_bib0205","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.vetmic.2014.04.014","article-title":"A bacterial engineered glycoprotein as a novel antigen for diagnosis of bovine brucellosis","volume":"172","author":"Ciocchini","year":"2014","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2016.02.025_bib0210","doi-asserted-by":"crossref","first-page":"e2048","DOI":"10.1371\/journal.pntd.0002048","article-title":"Development and validation of a novel diagnostic test for human brucellosis using a glyco-engineered antigen coupled to magnetic beads","volume":"7","author":"Ciocchini","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2016.02.025_bib0215","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1475-2859-11-13","article-title":"Exploiting the Campylobacter jejuni protein glycosylation system for glycoengineering vaccines and diagnostic tools directed against brucellosis","volume":"11","author":"Iwashkiw","year":"2012","journal-title":"Microb Cell Fact"},{"key":"10.1016\/j.vaccine.2016.02.025_bib0220","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/j.ajpath.2015.03.003","article-title":"Pathogenesis and immunobiology of brucellosis: review of Brucella-host interactions","volume":"185","author":"de Figueiredo","year":"2015","journal-title":"Am J Pathol"},{"key":"10.1016\/j.vaccine.2016.02.025_bib0225","first-page":"3","article-title":"Food safety: at the center of a One Health approach for combating zoonoses","volume":"366","author":"Wielinga","year":"2013","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2016.02.025_bib0230","doi-asserted-by":"crossref","first-page":"e1003454","DOI":"10.1371\/journal.ppat.1003454","article-title":"CD4+ T cell-derived IL-10 promotes Brucella abortus persistence via modulation of macrophage function","volume":"9","author":"Xavier","year":"2013","journal-title":"PLoS Pathog"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16001675?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16001675?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,15]],"date-time":"2020-09-15T16:32:45Z","timestamp":1600187565000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X16001675"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":23,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["S0264410X16001675"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.02.025","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Delta-pgm, a new live-attenuated vaccine against Brucella suis","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.02.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}